Trauma-informed Cognitive Behavioural Therapy (TiCBT) to Aid Reintegration of Repentant Terrorists and Their Families in Nigeria: A Pilot Study

Sponsor
Tarela Ike (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05449353
Collaborator
British International Studies Association (Other)
24
1
11

Study Details

Study Description

Brief Summary

The aim of the study is to describe the feasibility, cultural appropriateness, and acceptability of Trauma-informed Cognitive Behaviour Therapy (TiCBT) to promote community healing and encourage the reintegration of repentant terrorists and their families to avoid reoffending.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Trauma-informed Cognitive Behaviour Therapy (TiCBT)
N/A

Detailed Description

The study will adopt a mixed-method single-arm experimental design. Approximately 24 participants will be recruited for the intervention. The Trauma-informed Cognitive Behaviour Therapy (TiCBT) is an 8-session intervention lasting approximately 1 hour each and designed to address trauma, dispel negative attitudes and encourage positive behaviour towards repentant terrorists. Measurement will be collected at baseline pre-intervention, end of intervention and three months post-intervention to determine its feasibility and effectiveness. Interviews will also be conducted post-intervention. Repeated-measures univariate analyses of variance (ANOVA) will be performed to examine differences between the pre- and post-intervention stages. Interviews will be analysed using thematic analysis.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
24 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Trauma-informed Cognitive Behavioural Therapy (TiCBT) to Aid Reintegration of Repentant Terrorists and Their Families in Nigeria: A Pilot Study
Anticipated Study Start Date :
Jul 31, 2022
Anticipated Primary Completion Date :
May 30, 2023
Anticipated Study Completion Date :
Jun 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Trauma-infomed Cognitive Behavioural Therapy

Experimental (n=24 participants) will receive the TiCBT which consists of a total of 8-group integrated sessions lasting approximately 60 minutes per session every 3 days interval with 24 persons in the single group.

Behavioral: Trauma-informed Cognitive Behaviour Therapy (TiCBT)
Group: Experimental (n=24 participants) will receive the TiCBT which consists of a total of 8-group integrated sessions lasting approximately 60 minutes per session every 3 days interval with 24 persons in the single group.

Outcome Measures

Primary Outcome Measures

  1. Trauma Screening Questionnaire [Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention]

    Change in traumatic experience is being assessed

  2. Patient Health Questionnaire [Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention]

    Change in depression is being assessed

  3. Attitude Towards Repentant Terrorists and their Reintegration Scale [Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention]

    Change in of attitude towards repentant terrorists is being assessed

  4. brief Verona Service Satisfaction Scale [Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention]

    Change in service satisfaction is being assessed

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • community members who are victims of Boko Haram terrorism and had previous experiences of trauma/depression,

  • score five and above for the culturally-adapted Trauma Screening Questionnaire (Brewinn et al., 2002)

  • aged 18+ years,

  • able to give informed consent,

  • speak English

  • are residents or from areas within Nigeria including Maiduguri, Adamawa, and Plateau environs.

Exclusion Criteria:
  • less than 18 or above 85 years

  • unable to give consent

  • clinically diagnosed with severe PTSD/suicidal ideations or undergoing treatment

  • temporary or non-residents who are unlikely to be available for follow up

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Tarela Ike
  • British International Studies Association

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tarela Ike, Dr, Teesside University
ClinicalTrials.gov Identifier:
NCT05449353
Other Study ID Numbers:
  • 0000-0003-0516-0313a
First Posted:
Jul 8, 2022
Last Update Posted:
Jul 8, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 8, 2022